What is your approach to DVT prophylaxis in patients who require IVIG but are at increased risk for thrombotic events?

I am unaware of any published data to guide the decision-making for this topic. Empirically, I recommend low-dose aspirin in patients >50 who have to get long-term IVIG especially if there are a lot of underlying risk factors for thrombosis like diabetes, immobility, etc. Again, this is not an evide...

There's not much available literature on this, but the risk is probably related to peak dosing. I couldn’t find a report of thrombosis with SCIg, but the warning is there and the risk must be very low. So, I would use SCIg when I can. Otherwise, my approach is to spread the treatment out; lower dose...